Stem Cell Therapy for High-Risk Neuroblastoma: Stem Cell Transplantation and Targeting Cancer Stem Cells
Book chapter (January 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation
Article in European Journal of Nuclear Medicine and Molecular Imaging (November 2021)
Killer‐cell immunoglobulin‐like receptor ligand mismatch cord blood transplantation in high‐risk neuroblastoma
Article in Pediatrics International (June 2019)